Coronary artery disease treatment
CA 2501232 A1 · Owner: Genvec, Inc. · Inventors: Fischer, Paul M.; Pressler, Milton L.; Yonehiro, Grant
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides a method of treating coronary artery disease in a human patient comprising directly injecting into an ischemic cardiac muscle via , multiple injections to different points of the cardiac muscle a dose of a , pharmaceutical composition comprising a pharmaceutically acceptable carrier and a replication-deficient adenoviral vector comprising a nucleic acid sequence encoding an angiogenic peptide operably linked to a promoter whereby , the coronary artery disease is treated. Figure 1 is a bar graph that depicts the change in time to at least 1 mm ST-segment depression on exercise electrocardiogram (ECG) from baseline at 12 weeks and 26 weeks post-treatment in …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 14, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 14, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 14, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.